市场调查报告书
商品编码
1500601
手术缝线市场:按类型、材料、应用和最终用户划分 - 全球预测 2024-2030Surgical Suture Market by Type (Monofilament Sutures, Multifilament Sutures), Material (Absorbable, Non-Absorbable), Application, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年手术缝线市场规模为48亿美元,预计2024年将达50.8亿美元,2030年将达70.7亿美元,复合年增长率为5.67%。
手术缝合线是在癒合过程中连接伤口或切口附近皮肤边缘的医疗设备。缝合线通常用于各种外科手术,包括内伤和外伤。手术缝合线由多种材料製成,包括天然材料(丝绸和肠线)、合成材料(尼龙和聚丙烯)和可吸收材料(Polyglycolic和聚乳酸)。为了优化伤口缝合併促进正确癒合,可以采用多种模式进行缝合,包括简单间断缝合、连续缝合和褥式缝合。此外,老年人经常需要针对各种医疗状况进行手术干预,包括关节关节重建、心血管手术和癌症治疗,这增加了对手术缝合的需求。然而,用于手术缝合的多种替代创伤护理管理产品和频繁的破损问题阻碍了它们的使用。此外,材料科学和技术的进步导致了性能改进的新型缝合材料的开发。
主要市场统计 | |
---|---|
基准年[2023] | 48亿美元 |
预计年份 [2024] | 50.8亿美元 |
预测年份 [2030] | 70.7亿美元 |
复合年增长率(%) | 5.67% |
区域洞察
由于医疗保健行业完善、外科手术数量不断增加以及先进医疗技术的高采用率,美洲的手术缝线市场正在成长。该市场的整容手术正在兴起,刺激了对手术缝合线的需求。医疗保健产业的进步、人口老化的加剧以及对高品质和可靠产品的强烈偏好导致欧洲、中东和非洲地区对手术缝合线的需求增加。在医院和诊所的增加以及政府对医疗基础设施现代化的努力的推动下,中东和非洲的手术缝合线市场正在稳步增长。医疗基础设施的不断改善、庞大的人口基数以及对开发新材料和技术的日益关注正在影响亚太地区手术缝线市场的成长。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在手术缝线市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可对手术缝线市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在手术缝合线市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[182 Pages Report] The Surgical Suture Market size was estimated at USD 4.80 billion in 2023 and expected to reach USD 5.08 billion in 2024, at a CAGR 5.67% to reach USD 7.07 billion by 2030.
Surgical sutures are medical devices that hold together the edges of skin near the wound or incision during the healing process. They are commonly employed in various surgical procedures, including internal and external wounds. Surgical sutures are made of multiple materials, including natural substances (silk or catgut), synthetic materials (nylon or polypropylene), or absorbable materials (polyglycolic acid or polylactic acid). Sutures can be placed in different patterns, such as simple interrupted, continuous, or mattress sutures, to achieve optimal wound closure and promote proper healing. Moreover, older adults often require more surgical interventions for various medical conditions, including joint replacements, cardiovascular surgeries, and cancer treatments, increasing the need for surgical sutures. However, various alternative wound care management products and frequent breakage problems in surgical sutures impede their use. Additionally, material science and technology advances have led to the development of new suture materials with improved properties.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 4.80 billion |
Estimated Year [2024] | USD 5.08 billion |
Forecast Year [2030] | USD 7.07 billion |
CAGR (%) | 5.67% |
Regional Insights
The surgical sutures market is growing in the Americas owing to the well-established healthcare sector, increased surgical procedures, and a high adoption rate of advanced medical technologies. The market is witnessing a growth in aesthetic and cosmetic surgeries, fueling the need for surgical sutures. Advancements in the healthcare sector, coupled with an increasing aging population and strong preference for high-quality and reliable products, are resulting in an increased need for surgical sutures in the EMEA region. The Middle East and Africa's surgical sutures market is growing steadily, driven by the increasing number of hospitals and clinics and government initiatives to modernize healthcare infrastructure. Continuous improvements in healthcare infrastructure, a large population base, and a growing emphasis on developing novel surgical suture materials and techniques are influencing the growth of the surgical sutures market in the APAC region.
Market Insights
The market dynamics represent an ever-changing landscape of the Surgical Suture Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Surgical Suture Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Surgical Suture Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Suturion and Healthcare 21 Sign Exclusive Distributor Agreement
Suturion has entered into an exclusive distribution agreement with Healthcare 21, an eminent innovative healthcare solutions provider. This agreement is anticipated to leverage Healthcare 21's robust distribution network to heighten the accessibility and availability of Suturion's advanced suture technology to healthcare professionals across the United Kingdom. [Published On: 2023-10-17]
Genesis MedTech secures China's NMPA Approval for Absorbable Sutures
Genesis MedTech Group achieved a milestone with the National Medical Products Administration's (NMPA) authorization of its novel absorbable surgical sutures. This innovative product, engineered to dissolve within the body over time, promises to enhance the standard of surgical care in the region by reducing the necessity for follow-up procedures to remove sutures, thus contributing to improved patient recovery experiences. [Published On: 2023-09-12]
Riverpoint Medical Invests USD 10 Million In Its New Facilities And Manufacturing Site In The Coyol Free Trade Zone
Riverpoint Medical expanded its operational footprint with a significant USD 10 million investment in a new facility in Costa Rica's Coyol Free Trade Zone. This substantial financial commitment underscores the company's dedication to growth and its intent to optimize production efficiencies and elevate product quality. The new site is poised to bolster the company's manufacturing capabilities, particularly in producing surgical sutures, a critical segment in the medical supply industry. [Published On: 2023-08-22]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Surgical Suture Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Surgical Suture Market, highlighting leading vendors and their innovative profiles. These include Able Medical Devices Inc., AD Surgical, Advanced Medical Solutions Group plc, AIP Medical SA, Atramat by Internacional Farmaceutica S.A . de C.V., B. Braun SE, Centenial Surgical Suture Ltd., CONMED Corporation, Corza Medical GmbH, DemeTECH Corporation, Demophorius Healthcare Ltd., Dolphin Sutures, Genesis Medtech, GMD Group, Healthium Medtech Ltd., Johnson & Johnson Services, Inc., Lotus Surgicals Pvt Ltd, Lux Sutures SA, Lydus Medical, McKesson Medical-Surgical Inc., Medtronic PLC, Mellon Medical B.V., Orion Sutures India Pvt Ltd, Peters Surgical, Riverpoint Medical, Shandong Haidike Medical Products Co.,Ltd., Smith & Nephew PLC, Stryker Corporation, Sutumed Corp., SUTUREGARD Medical, Inc., Teleflex Incorporated, Unisur Lifecare Pvt. Ltd., Vitrex Medical A/S, and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage